Skip to main content
LIFECOME BIOCHEMISTRY CO., LTD. logo

LIFECOME BIOCHEMISTRY CO., LTD. — Investor Relations & Filings

Ticker · 002868 ISIN · CNE100002QH2 LEI · 65560089EP03NANEN790 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,742 across all filing types
Latest filing 2024-08-27 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002868

About LIFECOME BIOCHEMISTRY CO., LTD.

https://www.pclifecome.com

Lifecome Biochemistry Co., Ltd. focuses on the research, development, and large-scale production of fermentation-based veterinary pharmaceuticals and feed additives. The company’s core product portfolio includes Bacitracin Zinc, Bacitracin Methylene Disalicylate (BMD), and Colistin Sulfate, available in both active pharmaceutical ingredient (API) and premix forms. These biochemical products are primarily utilized in the livestock and poultry sectors to manage enteric health and improve feed efficiency. The organization operates advanced fermentation and purification facilities, maintaining compliance with international Good Manufacturing Practices (GMP) and various global regulatory standards. By leveraging specialized biotechnological processes, the company provides high-purity solutions aimed at enhancing animal nutrition and disease prevention across international markets.

Recent filings

Filing Released Lang Actions
关于全资子公司完成工商注册登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of business registration for a wholly-owned subsidiary of the company. It details the registration information such as company name, legal representative, registered capital, and business scope. There is no financial data, no report attached or referenced as being published, and no mention of financial results or regulatory certifications. This is a corporate announcement about a subsidiary's registration, which does not fit into financial reports or regulatory filings categories. It is a general regulatory announcement about corporate structure and business registration, best classified under Regulatory Filings (RNS).
2024-08-27 Chinese
上海澄明则正律师事务所关于绿康生化股份有限公司2024年第三次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and validity of the procedures, attendance, and voting results of the 2024 third extraordinary general meeting of shareholders of a company. It details the convening, attendance, voting procedures, and results of the shareholder meeting. This document is not the meeting materials themselves, nor is it a report of financial results or management commentary. It is a legal opinion related to the shareholder meeting, which is typically classified under announcements related to voting results or shareholder meeting outcomes. Given the detailed voting results and the nature of the document focusing on the shareholder meeting's legality and voting outcomes, the most appropriate classification is "Declaration of Voting Results & Voting Rights Announcements (DVA)". The document length and content confirm it is not a brief announcement or a report publication announcement, but a substantive legal opinion on the meeting and voting results.
2024-08-26 Chinese
2024年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement for the "2024 Third Extraordinary General Meeting of Shareholders" of the company. It details the meeting date, attendance, voting results on various proposals, and legal witness statements. The content focuses on the official voting outcomes and procedural compliance of a shareholders' meeting. It does not contain financial statements, management discussion, or detailed report content. The document length is about 3,061 characters, which is relatively short and consistent with a formal announcement of voting results rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-08-26 Chinese
关于召开2024年第三次临时股东大会的提示性公告
AGM Information Classification · 95% confidence The document is a detailed announcement about the convening of the company's 2024 third extraordinary general meeting of shareholders, including meeting time, voting procedures (both onsite and online), agenda items, and proxy voting instructions. It does not contain financial statements or results but rather logistical and procedural information about the shareholders' meeting. The document is not a report itself but an announcement related to a shareholders' meeting. It is not a voting results declaration since it is issued before the meeting date. It fits best as an AGM Information document, which covers presentations and materials shared during or about the Annual or Extraordinary General Meeting. The document length is about 4511 characters, which is consistent with a detailed meeting notice rather than a full report. Therefore, the classification is AGM Information (AGM-R).
2024-08-19 Chinese
第五届监事会第四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of the company 绿康生化股份有限公司 regarding the fourth meeting of the fifth Supervisory Board. It includes details about the meeting attendance, the agenda item (approval of a related party transaction proposal), and voting results. The document is short (664 characters) and serves as an official announcement of the meeting's resolutions rather than a full report or detailed financial disclosure. It does not contain financial statements or detailed management discussion. This type of document fits best under the category of Regulatory Filings (RNS), as it is a general regulatory announcement about corporate governance activities and meeting resolutions that do not fit other specific categories.
2024-08-08 Chinese
简式权益变动报告书（肖菡）
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the reduction in shareholding by an individual shareholder (肖菡) in the company 绿康生化股份有限公司. The document includes specifics about the shareholding before and after the transaction, the method of reduction (block trade), and compliance with relevant Chinese securities laws and regulations. It is a formal disclosure of a change in significant share ownership, specifically a decrease in shares held by a shareholder. This matches the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. The document is not an annual report, earnings release, or any other type of report but a regulatory disclosure about shareholding changes.
2024-08-08 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.